Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study

scientific article published in December 2003

Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0026-0495(03)00313-5
P698PubMed publication ID14669165

P2093author name stringBjörn Fagerberg
Lillemor Mattsson Hultén
Johannes Hulthe
P2860cites workDefinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultationQ29547453
Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemiaQ33946056
Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.Q35846048
Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humansQ44007232
Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolismQ44286338
Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol.Q44358356
The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) studyQ47230186
Relationship of LDL size to insulin sensitivity in normoglycemic men.Q47305592
Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.Q51590377
The euglycemic hyperinsulinemic clamp examination: variability and reproducibilityQ73658021
P433issue12
P921main subjectlipoproteinQ28350
metabolic syndromeQ657193
insulin resistanceQ1053470
atherosclerosisQ12252367
P304page(s)1612-1614
P577publication date2003-12-01
P1433published inMetabolismQ15764354
P1476titleLow adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study
P478volume52

Reverse relations

cites work (P2860)
Q37801629A Personalized Approach to Metabolic Aspects of Obesity
Q37801870Adiponectin action from head to toe.
Q36058331Adiponectin in women with polycystic ovary syndrome
Q36925634Adiponectin, obesity and atherosclerosis
Q33984448Adiponectin--journey from an adipocyte secretory protein to biomarker of the metabolic syndrome
Q51446231Adiponectin: possible link between metabolic stress and oxidative stress in the elderly.
Q46160956Adiposity in childhood is related to C-reactive protein and adiponectin in young adulthood: from the Bogalusa Heart Study
Q57416310Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters
Q44361282Associations of small dense low-density lipoprotein and adiponectin with complications of type 2 diabetes
Q42368807Cholesterotic Fibrous Histiocytoma in a Patient with Metabolic Syndrome
Q36675450Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles
Q85055778Clinically silent adrenal adenomas - their relation to the metabolic syndrome and to GNB3 C825T gene polymorphism
Q53525100Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
Q46655152Decreased adiponectin levels in familial combined hyperlipidemia patients contribute to the atherogenic lipid profile
Q36772884Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?
Q80594525Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men
Q35086818Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo
Q37074239Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering Agents
Q36706541Epidemiologic evidence on serum adiponectin level and lipid profile
Q38077655Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?
Q28235973Immunologic profile of excessive body weight
Q46165782Insulin resistance without obesity induced by cotton pellet granuloma in mice
Q35791843Inverse correlation between serum adiponectin and 8-iso-prostaglandin F2α in newly diagnosed type 2 diabetes patients
Q37054329Metabolic syndrome and skin: psoriasis and beyond
Q46923692Multimers and adiponectin gene 276G>T polymorphism in the Japanese population residing in rural areas
Q36850779Pathophysiological significance of adiponectin
Q36127599Plasma Adiponectin Levels in Elderly Patients with Prediabetes
Q35549836Pollock oil supplementation modulates hyperlipidemia and ameliorates hepatic steatosis in mice fed a high-fat diet
Q34809082Pre-pubertal children born post-term have reduced insulin sensitivity and other markers of the metabolic syndrome
Q41582154Prevalence of Metabolic Syndrome in Patients with Mucosal Lichen Planus: A Case-Control Study
Q35952447Prevention and treatment of the metabolic syndrome.
Q37667536Proposed role of calcium and dairy food components in weight management and metabolic health
Q37743164Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions
Q37603130Role of adipocytokines in predicting the development of diabetes and its late complications
Q34012837Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes
Q51803379Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
Q33627496Serum leptin and adiponectin levels in Korean patients with psoriasis.
Q50970036Serum leptin, adiponectin, resistin and ghrelin levels in psoriatic patients treated with cyclosporin.
Q46923553Serum total and high molecular weight adiponectin levels are correlated with the severity of diabetic retinopathy and nephropathy
Q53621798Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations.
Q36359882Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease

Search more.